Imagine Eyes’ AO retinal imaging system receives regulatory clearance in Japan
We are happy to announce that the rtx1-e Adaptive Optics Retinal Camera has received regulatory clearance in Japan.
Imagine Eyes enters a new distribution partnership with Chuo Sangio Co. in Japan
March 21, 2017, Orsay, France, and Nishinomiya, Japan . Imagine Eyes® has signed an exclusive distribution agreement with Chuo Sangio Co. to sell its rtx1-e Adaptive Optics Retinal Camera in Japan.
New rtx1-e up and running at the University of Tübingen
Orsay, France and Tubingen, Germany, Feb 14, 2017. Imagine Eyes is proud to announce the installation of an rtx1-e Adaptive Optics Retinal Camera at the brand new University Eye Hospital of Tübingen in Germany.
Imagine Eyes grateful to rtx1-e workshop presenters at the 2016 Ophthalmic Imaging congress in Paris
Imagine Eyes’ wants to express many thanks to Dr Sarah Mrejen and Pr Michel Paques, who presented a workshop on the rtx1-e Adaptive Optics Retinal Camera at the « Ophthalmic Imaging: from Theory to Practice » congress, on September 30th, 2016, at the CAP 15 Congress Center in Paris, France.
Many thanks to visitors and speakers at Euretina 2016!
Imagine Eyes’ team wishes to thank all the congress attendees who visited our booth at the Euretina 2016 meeting in Copenhagen. We hope that everyone enjoyed our live demonstrations of ultrahigh-resolution retinal imaging, as well as our software tools for analyzing the retina at the cellular and microvascular levels.
We are also very grateful to Dr Jelena Potic (Jules Gonin Hospital, Lausanne, Switzerland) and Dr Kiyoko Gocho (Nippon medical School, Chiba, Japan) for presenting new clinical results obtained with the rtx1 Adaptive Optics Retinal Camera.
Imagine Eyes and Miloftalmica enter a partnership to develop AO imaging business in Italy
September 1st 2016, Orsay, France and Milano, Italy. Imagine Eyes® announces a new business partnership with Miloftalmica™. Both companies signed an agreement in which Imagine Eyes appoints Miloftalmica as the exclusive distributor of its ultrahigh-resolution retinal imaging products in Italy.
Imagine Eyes enters a new distribution partnership with InView Medical
June 6th 2016, Orsay and Wroclaw. Imagine Eyes® is pleased to announce a new distribution partnership with InView Medical™. Both companies signed an agreement in which Imagine Eyes appoints InView Medical as the exclusive distributor of its ultrahigh-resolution retinal imaging products in the Republic of Poland and neighboring countries including the Czech Republic, Estonia, Hungary, Lithuania, Latvia and Slovakia. Read more
ARVO 2016 in Seattle : Imagine Eyes is very grateful to rtx1 users for their many high-quality presentations
Our team at Imagine Eyes wants to express its deepest thanks to rtx1 users for presenting many scientific lectures and posters at the ARVO meeting in Seattle in May 2016. And special thanks to Dr Michael J. Gale, Dr Kiyoko Gocho, Dr Marco Lombardo and Pr Michel Paques for together animating a fascniating photo quiz at Imagine Eyes users’ meeting. Read more
Imagine Eyes’ customers to present many new advances in ophthalmology and vision sciences at ARVO 2016
Imagine Eyes’ customers will present an incredible number of lectures and posters at the upcoming ARVO meeting in Seattle. Their presentations include the latest clinical results from multiple studies carried out using the rtx1 Adaptive Optics Retinal Camera in multiple pathologies, as well as new advances in vision science using Imagine Eyes’ AO components. Additionnaly, all through the ARVO meeting, our team will show live demos of cellular and micro-vascular retinal imaging at booth #1645. We’re looking forward to meeting you in Seattle! Read more
First implementation of rtx1 in psychiatric research
Feb 16th, 2016. An rtx1 Adaptive Optics Retinal Camera was for the first time implemented for use in psychiatric research at the « La Timone » Hospital in Marseille, France. The rtx1 unit was installed by Imagine Eyes’ partner PEMOA-Optitec at the hospital’s ophthalmology department led by Professor Louis Hoffart. The system is now used in a 6-month study carried out by Dr. Matonti on « multimodal imaging analysis in a population suffering from psychiatric troubles including schizophrenia”.
Click here to read more about the rtx1.
Click here to read more about PEMOA-Optitec (in French)